Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-14

Clinical Trial Update: taVNS Effect on Central Auditory Processing [NA]

View source ↗

Summary

This entry notes a completed clinical trial evaluating whether transcutaneous auricular vagus nerve stimulation (taVNS) influences central auditory processing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • taVNS device (transcutaneous auricular vagus nerve stimulator)

Snippet

Sponsor: Medipol University | Conditions: Central Auditory Disease, Auditory Processing Disorder, Central | NA | Status: COMPLETED